EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A nationwide trend analysis on the usage of endomyocardial biopsy

Karsten Keller iD, Sebastian Göbel, Tommaso Gori, Thomas Münzel, Philip Wenzel, Lukas Hobohm

Clinical Cardiology · 2024

DOI: 10.1002/clc.24198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Cardiology, 2024. Verfasst von Karsten Keller und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Cardiology I, University Medical Center Mainz (Johannes Gutenberg-University Mainz), Mainz, Germany. Hauptthemen laut MEDLINE: Heart Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Endomyocardial biopsy (EMB) is a safe procedure performed in diagnostic work‐up of cardiac disease. Hypothesis Data regarding temporal trends of total numbers, characteristics, in‐hospital outcomes, and complications of patients undergoing EMB are sparse.

Methods

The nationwide German inpatient sample (2005–2019) was used for this analysis. Patient cases of EBM during the 5‐year cycles from 2005 to 2009, 2010 to 2014, and 2015 to 2019 were compared, and temporal trends regarding total numbers and presumable major and minor EMB‐associated complications were investigated.

Results

Overall, 67 745 EMB were performed in Germany 2005–2019. Total number of EMB increased from 3083 in 2005 to 5646 in 2019 ( β 0.40 [95% confidence interval [CI] 0.37–0.43], p < .001). Among these EMB, 19 083 (28.2%) were performed during the period 2005–2009, 22 867 (33.7%) 2010–2014, and 25 795 (38.1%) between 2015 and 2019. The proportion of patients aged ≥70 years was highest 2015–2019 (2005–2009: 9.3%; 2010–2014: 13.8%; 2015–2019: 16.1%, p < .001) and the most aggravated comorbidity profile (Charlson Comorbidity Index 2.25 ± 1.93; 2.67 ± 2.14; 3.01 ± 2.29, p < .001) was also detected 2015–2019. Major complications occurred less often in the period 2015–2019 compared to 2005–2009 (odds ratio [OR] 0.921 [95% CI 0.893–0.950], p < .001), whereas minor complications were more frequently observed between 2015 and 2019 (OR 1.067 [95% CI 1.042–1.093], p < .001). While a decrease in major complications was detected irrespective of age, an increase in minor complications was identified only in patients between 30–59 years.

Conclusions

Annual numbers of EMB increased significantly in Germany 2005–2019. Patients who underwent EMB in recent years were older and showed an aggravated comorbidity profile accompanied by fewer major complications, underscoring safety of the procedure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart DiseasesHumansAdultMiddle AgedRetrospective StudiesBiopsyCardiac CatheterizationComorbidityMyocardium

Stichwörter der Autor:innen

complicationsendomyocardial biopsyheart failuremortality

Autor:innen und Institutionen

  • Department of Cardiology, Cardiology I, University Medical Center Mainz (Johannes Gutenberg-University Mainz), Mainz, Germany.
  • Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz (Johannes Gutenberg-University Mainz), Mainz, Germany.
  • Department of Sports Medicine, Medical Clinic VII, University Hospital Heidelberg, Heidelberg, Germany.
  • German Center for Cardiovascular Research (DZHK), Partner Site Rhine Main, Mainz, Germany.

ORCID-Profile: Karsten Keller

Zitieren

APA

Keller, K., Göbel, S., Gori, T., Münzel, T., Wenzel, P., & Hobohm, L. (2024). A nationwide trend analysis on the usage of endomyocardial biopsy. Clinical Cardiology. https://doi.org/10.1002/clc.24198

Vancouver

Keller K, Göbel S, Gori T, Münzel T, Wenzel P, Hobohm L. A nationwide trend analysis on the usage of endomyocardial biopsy. Clinical Cardiology. 2024. doi:10.1002/clc.24198

BibTeX
@article{Keller2024,
  author = {Keller, Karsten and Göbel, Sebastian and Gori, Tommaso and Münzel, Thomas and Wenzel, Philip and Hobohm, Lukas},
  title = {A nationwide trend analysis on the usage of endomyocardial biopsy},
  journal = {Clinical Cardiology},
  year = {2024},
  doi = {10.1002/clc.24198}
}
Kostenlos starten →